Skip to main content

Advertisement

Log in

Binding of urokinase to specific receptor sites on human breast cancer membranes

  • Experimental Oncology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

The high molecular weight form of the plasminogen activator urokinase (54 kD) binds to specific receptor sites on the cell membrane of breast carcinomas by its inactive "A" chain. The binding is of high affinity (range of dissociation constants: 5.6 X 10(-11) to 4 X 10(-10) mol l-1 and there were between 20 to 250 fmol of binding sites per milligram of membrane protein) and equilibrium is reached in 60 min. No competition for binding sites was observed with epidermal growth factor, tissue plasminogen activator or the low molecular weight form of urokinase (33 kD). Cross-linking experiments suggest that the receptor is a monomeric unit of molecular weight of 50 kD. This binding site provides a mechanism for the incorporation of urokinase into the cell membrane.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Needham, G., Sherbet, G., Farndon, J. et al. Binding of urokinase to specific receptor sites on human breast cancer membranes. Br J Cancer 55, 13–16 (1987). https://doi.org/10.1038/bjc.1987.3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1987.3

  • Springer Nature Limited

This article is cited by

Navigation